ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,455Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 50

$1.47M Total Retail Price of All Prescriptions

Rank: 2 out of 50

846 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 846 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 846 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 22,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,485 1,006 S3 1 1
SIMVASTATIN 945 810 2 5
LEVOTHYROXINE SODIUM 731 682 3 2
OMEPRAZOLE 600 497 4 7
POTASSIUM CHLORIDE 514 448 5 9
AMLODIPINE BESYLATE 476 440 6 6
TORSEMIDE 447 409 7 61
DONEPEZIL HCL 446 420 8 20
ZOLPIDEM TARTRATE 417 363 9 18
GLIMEPIRIDE 408 346 10 17
CLOPIDOGREL 396 377 11 29
FUROSEMIDE 393 344 12 3
GABAPENTIN 331 259 13 13
LISINOPRIL 324 300 14 8
MELOXICAM 311 266 15 16
FENTANYL 300 217 S2 16 97
SERTRALINE HCL 292 236 17 28
BYSTOLIC 282 251 18 82
PREDNISONE 280 238 19 33
METFORMIN HCL 279 237 20 4
TRAMADOL HCL 276 205 21 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 261 198 22 30
CARVEDILOL 254 232 23 27
CELEBREX 251 226 24 76
METOPROLOL SUCCINATE 251 229 24 22
AZITHROMYCIN 247 195 26 36
NEXIUM 243 172 27 15
WARFARIN SODIUM 242 210 28 19
PLAVIX 242 226 28 42
NAMENDA 228 228 30 25
PANTOPRAZOLE SODIUM 208 187 31 32
CLONIDINE HCL 207 176 32 23
TAMSULOSIN HCL 207 203 32 31
LANTUS 203 189 34 38
RAMIPRIL 198 168 35 59
AMOXICILLIN 196 165 36 87
DIGOXIN 193 189 37 40
AMIODARONE HCL 190 190 38 146
ALLOPURINOL 181 169 39 34
LEVOFLOXACIN 172 147 40 130
ATORVASTATIN CALCIUM 171 157 41 21
ESTRADIOL 169 139 R 42 136
CITALOPRAM HBR 165 147 43 24
METOPROLOL TARTRATE 159 154 44 12
HYDROCHLOROTHIAZIDE 158 143 45 10
LOSARTAN POTASSIUM 157 156 46 37
CIPROFLOXACIN HCL 146 138 47 41
DIOVAN HCT 139 131 48 46
LOSARTAN-HYDROCHLOROTHIAZIDE 138 109 49 93
PRAVASTATIN SODIUM 138 115 49 14
LYRICA 136 95 51 55
METHOCARBAMOL 129 115 R 52 84
DIOVAN 129 118 52 35
EXFORGE 124 97 54 149
ESCITALOPRAM OXALATE 122 121 55 43
CHLORTHALIDONE 120 119 56 179
SYNTHROID 118 104 57 57
MEGESTROL ACETATE 117 117 R 58 77
ADVAIR DISKUS 117 92 58 54
AMOX TR-POTASSIUM CLAVULANATE 116 93 60 122
PRISTIQ ER 115 102 61 180
SPIRONOLACTONE 111 111 62 88
VYTORIN 111 109 62 183
BISOPROLOL FUMARATE 108 95 64 185
CYCLOBENZAPRINE HCL 107 55 R 65 63
PRADAXA 106 106 66 187
BISOPROLOL-HYDROCHLOROTHIAZIDE 103 101 67 101
COLCRYS 102 88 68 188
AMLODIPINE BESYLATE-BENAZEPRIL 101 92 69 49
MECLIZINE HCL 91 85 70 86
LORAZEPAM 91 91 70 191
FLUTICASONE PROPIONATE 90 83 72 75
AMITRIPTYLINE HCL 88 63 R 73 39
NYSTATIN-TRIAMCINOLONE 88 63 73 193
ATENOLOL 87 81 75 26
ZETIA 84 75 76 115
COUMADIN 83 56 77 197
FLUOXETINE HCL 82 69 78 60
PROMETHAZINE HCL 81 67 R 79 69
EXELON 80 80 80 91
PREMARIN 77 62 R 81 123
CRESTOR 77 74 81 47
MICARDIS HCT 76 76 83 202
ROPINIROLE HCL 73 73 84 101
DOXAZOSIN MESYLATE 71 70 85 58
TRIAMCINOLONE ACETONIDE 71 53 85 178
QUETIAPINE FUMARATE 70 51 87 52
MORPHINE SULFATE ER 68 27 S2 88 211
DEXILANT 68 64 88 211
JANUVIA 67 42 90 124
ALPRAZOLAM 67 67 90 108
CARBIDOPA-LEVODOPA 67 67 90 139
ALENDRONATE SODIUM 66 51 93 68
CYMBALTA 66 43 93 45
NAPROXEN 66 63 93 62
FLUCONAZOLE 65 49 96 170
METFORMIN HCL ER 65 55 96 89
ZIPRASIDONE HCL 65 61 96 131
LANOXIN 65 65 96 214
SPIRIVA 65 57 96 90
LIVALO 61 61 101 220
SINGULAIR 61 48 101 142
MIRTAZAPINE 61 61 101 73
ISOSORBIDE MONONITRATE ER 59 50 104 74
NADOLOL 58 58 105 228
ARICEPT 57 57 106 230
CLONAZEPAM 57 49 106 170
HYDROXYZINE HCL 56 54 R 108 180
FLUDROCORTISONE ACETATE 55 43 109 235
PACERONE 55 44 109 235
LIPITOR 54 54 111 118
ESTROPIPATE 53 53 R 112 241
METHADONE HCL 52 26 S2 113 137
ACIPHEX 51 51 114 250
LANSOPRAZOLE 51 28 114 167
DILTIAZEM 24HR ER 50 50 116 251
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.